BACK TO WCN HOMEPAGE


Select the Exhibitor of your interest to retrieve the information:

CPC MainTheme Abstracts
Exhibitor:
Allergan Ltd Pfizer Inc Boehringer Ingelheim Lippincott Williams & Wilkins BMJ Publishing Group www.doctors.net.uk Oxford University Press UCB Pharma American Academy of Neurology Association of British Neurologists World Federation of Neurology Multiple Sclerosis Society Guillain-Barré Syndrome Foundation International Blackwell Science Ltd Martin Dunitz Ltd Harcourt Publishers Ltd GlaxoSmithKline Merck Sharp & Dohme Teva Pharmaceutical Industries Ltd Oxford Instruments Eisai Orion Pharma Elan Pharmaceuticals CJD Support Network Janssen-Cilag Tunis, Tunisia - WCN 2005 The National Hospital for Neurology and Neurosurgery European Dana Alliance for the Brain Neuroscan Medical Systems Eli Lilly and Company Cambridge University Press MedLink Corporation Butterworth-Heinemann European Federation of Neurological Societies New England Journal of Medicine Cadwell Laboratories Inc. The Parkinson's Disease Society Nycomed Amersham Cyberonics Serono International S.A. Asociación Colombiana de Neurología Lundbeck Aventis Pharma Pharmacia Corporation Genactics - Europe & USA 5th European Congress on Epileptology Octapharma Cambridge Laboratories Servier Laboratories Ltd Elsevier Science Ipsen Compumedics Limited Sydney, Australia - WCN 2005 Time Research Merz & Co GmbH & Co Novartis Pharma AG Cephalon UK Ltd Biogen Schering AG Headway - The Brain Injury Association Headway - The Brain Injury Association Bangkok, Thailand - WCN 2005 Madrid, Spain, WCN 2005 Cambridge Neurotechnology Ltd

Exhibitor Info:

Janssen-Cilag (49 & 65)

Turnhoutseweg 30
B-2340
Beerse
Belgium
Tel: +32-14-606085
Fax: +32-14-606117
Email: hbrouns@janbe.jnj.com
Contact: Hilde Brouns
Today, neurological disorders are increasingly recognised as a significant threat to health and quality of life. Novel treatments from Janssen-Cilag for CNS disorders provide optimism for the future. Janssen-Cilag's continued commitment to research and ongoing, long-term investment in the practice of neurology are yielding results in the areas of Alzheimer's disease, dementia and epilepsy. Together with neurologists and other clinicians, we aim to change the view of neurological disorders worldwide, while helping to solve some of the mysteries of neuropathophysiology.
Exhibition open:
Sunday 17 June
16.00 - 20.30
Monday 18 June
09.00 - 17.30
Tuesday 19 June
09.00 - 17.30
Wednesday 20 June
09.00 - 17.30
Thursday 21 June
09.00 - 17.30
Friday 22 June
09.00 - 18.30

Congress Information System ON-SITE

During the congress, the WCN Congress Information System will also be available. Computers will be placed against the wall in the entrance to the session hall 1, 2 and 3 where you can search the scientific programme,make your own Personal Planner, search the Abstracts, locate Exhibitors and look up City Information.


Back to Top